Cibc Private Wealth Group, LLC Crispr Therapeutics Ag Transaction History

Cibc Private Wealth Group, LLC

$51.3 Billion
Q1 2025

A detailed history of Cibc Private Wealth Group, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 1,995 shares of CRSP stock, worth $123,630. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,995

Previous 1,345 48.33%

Holding current value

$123,630

Previous $52,000 28.85%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$34.03 - $53.02 $22,119 - $34,463	650 Added 48.33%	1,995 $67,000
Q2 2024 Aug 09, 2024	SELL	$51.17 - $68.18 $13,764 - $18,340	-269 Reduced 16.67%	1,345 $72,000
Q1 2024 May 10, 2024	SELL	$60.67 - $89.12 $654,083 - $960,802	-10,781 Reduced 86.98%	1,614 $110,000
Q4 2023 Feb 13, 2024	BUY	$38.62 - $72.18 $478,694 - $894,671	12,395 New	12,395 $775,000
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $337,272 - $462,465	5,520 New	5,520 $361,000
Q1 2022 May 16, 2022	SELL	$53.19 - $79.24 $4,733 - $7,052	-89 Reduced 1.59%	5,520 $346,000
Q4 2021 Feb 08, 2022	SELL	$70.09 - $111.29 $9,812 - $15,580	-140 Reduced 2.44%	5,609 $425,000
Q3 2021 Nov 12, 2021	SELL	$110.2 - $156.64 $1.17 Million - $1.66 Million	-10,575 Reduced 64.78%	5,749 $643,000
Q2 2021 Aug 16, 2021	SELL	$100.84 - $161.89 $1.46 Million - $2.34 Million	-14,481 Reduced 47.01%	16,324 $2.64 Million
Q1 2021 May 12, 2021	BUY	$110.72 - $210.04 $2.74 Million - $5.2 Million	24,735 Added 407.5%	30,805 $3.75 Million
Q4 2020 Feb 12, 2021	SELL	$79.67 - $173.23 $18,324 - $39,842	-230 Reduced 3.65%	6,070 $929,000
Q3 2020 Nov 03, 2020	BUY	$78.5 - $100.64 $494,550 - $634,032	6,300 New	6,300 $527,000
Q2 2020 Aug 13, 2020	SELL	$38.5 - $76.05 $188,265 - $371,884	-4,890 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$33.68 - $62.53 $16,840 - $31,265	500 Added 11.39%	4,890 $207,000
Q4 2019 Jan 30, 2020	BUY	$36.68 - $73.13 $161,025 - $321,040	4,390 New	4,390 $267,000
Q3 2018 Nov 14, 2018	SELL	$44.35 - $65.71 $17,074 - $25,298	-385 Closed	0 $0
Q2 2018 Aug 02, 2018	SELL	$42.62 - $73.59 $5,966 - $10,302	-140 Reduced 26.67%	385 $23,000
Q1 2018 May 17, 2018	BUY	$23.52 - $58.17 $12,348 - $30,539	525 New	525 $24,000

Others Institutions Holding CRSP

# of Institutions

541

Shares Held

68.5M

Call Options Held

3.67M

Put Options Held

2.25M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.83B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.

Account

Cibc Private Wealth Group, LLC Crispr Therapeutics Ag Transaction History